Replies to post #28371 on The Rising Influence of Rising Affluence

[Whalatane]

Dew

Investors excited about Nvidia artificial intelligence, and AI’s ability to drive earnings and stock growth got a nice tidbit from an unexpected source Wednesday evening: Tesla CEO Elon Musk. “We’re using a lot of Nvidia (ticker: NVDA) hardware…we’ll actually take Nvidia hardware as fast as Nvidia will deliver it to us,” said Musk on his company’s second-quarter conference call.
Tesla (TSLA) needs Nvidia hardware, and the associated software, to improve its self-driving software.

( Barons )
Been on vacation ..may comment on AMRN later on your biotech values board
Kiwi

[DewDiligence]

ABT inks deal to_sell biosimilars in emerging markets:

https://www.prnewswire.com/news-releases/abbott-broadens-access-to-cutting-edge-biosimilars-in-key-emerging-markets-301932956.html

In emerging markets, consumers care greatly about the reputation of the manufacturer, which is why so-called “branded generics” can be a high-margin business for a company such as ABT. Biosimilars are a natural fit for ABT’s existing business in off-patent small-molecule drugs, which comprises 13% of ABT’s overall corporate sales (#msg-172393746).